SULSA is delighted to be working with Exscientia to deliver this online event on 9th November via Zoom from 12:00 – 13:30.
Xcellomics is aiming to enhance translation of novel biology and expedite early-stage drug discovery research in academia, with an aspiration to accelerate the creation of new medicines. For more information visit www.xcellomics.com.
Event welcome: Professor Michael Barrett (SULSA)
Phenotypic screening and Xcellomics collaboration: Professor Daniel Ebner and Dr Denise Barrault (University of Oxford / Exscientia)
Participant journey and collaboration benefits: Dr Cayetana Vázquez (Exscientia)
Taming Hippos: Dr Carsten Hansen (University of Edinburgh)
Discussion on industrial-academic collaborations and Xcellomics (open to meeting partcipants to ask your questions): Dr Denise Barrault and Dr Cayetana Vázquez (Exscientia)
To register for this free webinar please visit: https://www.eventbrite.co.uk/e/xcellomics-sulsa-virtual-event-tickets-432524451277
About Xcellomics: Xcellomics is a partnership between Exscientia, the University of Oxford Target Discovery Institute (TDI) and the global academic community aiming to enhance translation of novel biology. Our mission is to create a collaborative environment of research excellence and industrial expertise to expedite early-stage drug discovery research in academia, with an aspiration to accelerate the creation of new medicines.